A single dose of psilocybin shows months-long reductions in chronic suicidal ideation, with a small new study reporting durable effects and manageable acute risks

Psilocybin-assisted therapy produced rapid and lasting reductions in chronic suicidal ideation in a small new clinical study. Participants with long-standing suicidal thoughts received a single psilocybin dose with psychological support, and many showed meaningful improvement that persisted for months after treatment. The findings suggest that psychedelic treatment may affect entrenched patterns of hopelessness more quickly than conventional approaches. Acute adverse effects and intense experiences remained important safety considerations, but the reported benefits point to psilocybin as a promising investigational option for people with severe, persistent suicidality. The study adds to growing clinical interest in psilocybin for complex mental health conditions while also underscoring the need for larger controlled trials, careful screening, and structured therapeutic support.